Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 1.39% | $64.86M | €346.61B | 38.18% | 78 Outperform | |
| SAP SE | 1.00% | $46.43M | €273.22B | 4.56% | 73 Outperform | |
| Novartis AG | 0.98% | $45.88M | CHF188.17B | 3.27% | 78 Outperform | |
| HSBC Holdings | 0.93% | $43.44M | £180.66B | 47.15% | 79 Outperform | |
| Roche Holding AG | 0.92% | $42.86M | CHF209.25B | 3.87% | 73 Outperform | |
| Royal Bank Of Canada | 0.91% | $42.65M | $209.51B | 20.72% | 75 Outperform | |
| AstraZeneca | 0.82% | $38.04M | £192.33B | 7.56% | 75 Outperform | |
| Nestlé SA | 0.77% | $35.96M | CHF200.57B | 2.56% | 65 Neutral | |
| Banco Santander | 0.75% | $34.73M | €127.87B | 97.63% | 66 Neutral | |
| Allianz | 0.69% | $32.11M | €137.40B | 20.42% | 74 Outperform |